AT
ITCI

Avalon Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Avalon Trust’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-45
Closed -$5.94K – 476
2025
Q1 		$5.94K Hold
45
– – ﹤0.01% 382
2024
Q4 		$3.76K Buy
+45
New +$3.7K ﹤0.01% 385

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Avalon Trust's ITCI Position: Q2 2025 in Review

Avalon Trust sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 45 shares — an estimated $5.94K sold.

Avalon Trust first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $5.94K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Avalon Trust reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Avalon Trust sold 45 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $5.94K.
  • Avalon Trust first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
  • Avalon Trust's Intra-Cellular Therapies Inc. position peaked at $5.94K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Avalon Trust's 13F filing for Q2 2025, filed 8 Aug 2025.